Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults
Stroke is the second leading cause of death worldwide and accounts for >2 million deaths annually in China 1 , 2 . Ischemic stroke (IS) and intracerebral hemorrhage (ICH) account for an equal number of deaths in China, despite a fourfold greater incidence of IS 1 , 2 . Stroke incidence and ICH pr...
Saved in:
Published in | Nature medicine Vol. 25; no. 4; pp. 569 - 574 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.04.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Stroke is the second leading cause of death worldwide and accounts for >2 million deaths annually in China
1
,
2
. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) account for an equal number of deaths in China, despite a fourfold greater incidence of IS
1
,
2
. Stroke incidence and ICH proportion are higher in China than in Western populations
3
–
5
, despite having a lower mean low-density lipoprotein cholesterol (LDL-C) concentration. Observational studies reported weaker positive associations of LDL-C with IS than with coronary heart disease (CHD)
6
,
7
, but LDL-C-lowering trials demonstrated similar risk reductions for IS and CHD
8
–
10
. Mendelian randomization studies of LDL-C and IS have reported conflicting results
11
–
13
, and concerns about the excess risks of ICH associated with lowering LDL-C
14
,
15
may have prevented the more widespread use of statins in China. We examined the associations of biochemically measured lipids with stroke in a nested case-control study in the China Kadoorie Biobank (CKB) and compared the risks for both stroke types associated with equivalent differences in LDL-C in Mendelian randomization analyses. The results demonstrated positive associations of LDL-C with IS and equally strong inverse associations with ICH, which were confirmed by genetic analyses and LDL-C-lowering trials. Lowering LDL-C is still likely to have net benefit for the prevention of overall stroke and cardiovascular disease in China.
In a nested case-control study from the China Kadoorie Biobank, lowering blood low-density lipoprotein cholesterol levels confers lower risk for ischemic stroke but elevated risk for intracerebral hemorrhage, which was confirmed by genetic Mendelian randomization analyses. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1078-8956 1546-170X 1546-170X |
DOI: | 10.1038/s41591-019-0366-x |